Publication Name	World Journal of Virology
Manuscript ID	59595
Country	United States

Received	2020-09-18 21:29
Peer-Review Started	2020-09-18 21:30
To Make the First Decision
Return for Revision	2020-12-01 17:53
Revised	2020-12-02 17:07
Second Decision	2020-12-10 11:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-12-14 04:50
Articles in Press	2020-12-14 04:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-01-21 07:07
Publish the Manuscript Online	2021-01-21 13:09

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Review
Article Title	Emerging therapeutics in the management of COVID-19
Manuscript Source	Unsolicited Manuscript
All Author List	Asim Kichloo, Michael Albosta, Akshay Kumar, Michael Aljadah, Mohamed Mohamed, Zain El-Amir, Farah Wani, Shakeel Jamal, Jagmeet Singh and Akif Kichloo
Funding Agency and Grant Number
Corresponding Author	Michael Albosta, MD, Doctor, Department of Internal Medicine, Central Michigan University, 1632 Stone Street, Saginaw, MI 48602, United States. albos1ms@cmich.edu
Key Words	COVID-19; Therapeutics; Infectious disease; SARS-CoV-2; Pharmacology; Virology
Core Tip	As coronavirus disease 2019 continues to affect the global community, researchers are working diligently to determine the efficacy of therapeutic agents to fight this virus in clinical trials. Currently, there is a lack of published literature that comprehensively discusses all of the therapeutic agents under investigation. In this manuscript, we provide readers with a thorough and comprehensive evaluation of the current state of therapeutics including the proposed mechanisms of action, pharmacokinetics, recommended dosages, adverse effects, and efficacy data from clinical trials.
Publish Date	2021-01-21 13:09
Citation	Kichloo A, Albosta M, Kumar A, Aljadah M, Mohamed M, El-Amir Z, Wani F, Jamal S, Singh J, Kichloo A. Emerging therapeutics in the management of COVID-19. World J Virol 2021; 10(1): 1-29
URL	https://www.wjgnet.com/2220-3249/full/v10/i1/1.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i1.1

Full Article (PDF)	WJV-10-1.pdf
Full Article (Word)	WJV-10-1.docx
Manuscript File	59595_Auto_Edited.docx
Answering Reviewers	59595-Answering reviewers.pdf
Audio Core Tip	59595-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	59595-Conflict-of-interest statement.pdf
Copyright License Agreement	59595-Copyright license agreement.pdf
Peer-review Report	59595-Peer-review(s).pdf
Scientific Misconduct Check	59595-Bing-Fan JR-1.png
Scientific Misconduct Check	59595-Scientific misconduct check.pdf
Scientific Editor Work List	59595-Scientific editor work list.pdf